HPV test alone OK for cervical cancer screening over 30: expert panel

September 12, 2017

(HealthDay)—An influential U.S. panel of health experts is boosting support for the HPV test as a routine part of cervical cancer screening.

The independent U.S. Preventive Services Task Force (USPSTF)—which issues closely heeded guidelines on a range of medical issues—says the test for the human papillomavirus (HPV) can be used once every five years for women aged 30 to 65, in lieu of the once every three-year Pap test.

Prior guidelines had called for the use of both tests together.

For younger women, aged 21 to 29, a Pap test once every three years is still the recommended screen, the panel said.

Certain strains of sexually transmitted HPV are thought to cause the vast majority of cases.

"One of the biggest differences between these guidelines and the former guidelines is that the new guidelines recommend against co-testing—HPV test and a Pap test at the same time—for women at the ages of 30 to 65," noted Dr. Stephanie Blank, an ob/gyn who reviewed the guidelines.

Instead, "the new guidelines are recommending Pap alone with [follow-up lab tests] every three years or HPV testing alone every five years, but not both together," said Blank. She directs Women's Health at Mount Sinai Downtown Chelsea Center in New York City.

As she explained, the rationale behind the change was that—based on the evidence—there was no increase in deaths whether women got both tests together or just the one test.

According to the new USPSTF advisory, cervical screening is not recommended for women who are younger than 21, older than 65 (who have already had regular screenings when they were younger), and women of any age who do not have a cervix because they've undergone a hysterectomy.

The draft recommendation is a change from the panel's 2012 recommendation, which said that women aged 30 to 65 receive both the Pap test and HPV test at the same time.

The is an independent, volunteer panel of experts in prevention and evidence-based medicine. The draft recommendation is open for public comment on the task force's website between Sept. 12 and Oct. 9.

"Cervical cancer is highly curable when found and treated early," task force member Dr. Carol Mangione said in a panel news release.

"Most cases of cervical cancer occur in women who have not been regularly screened or treated," explained Mangione, who heads the division of general internal medicine and health services research at the University of California, Los Angeles' School of Medicine. "Therefore, making sure all are adequately screened and treated is critical to reducing deaths from cervical cancer."

Dr. Eva Chalas is chief of gynecological oncology at NYU Winthrop Hospital Cancer Center in Mineola, N.Y. Reviewing the new guidelines, she noted that "some European countries are using HPV as primary screening and only performing [the Pap ] as a secondary analysis."

Chalas added that "many physicians believe that this [newer] method provides greater accuracy for detection of both pre-cancerous and cancerous lesions. The Society of Gynecologic Oncology has supported HPV testing as described above for several years."

For her part, Blank said the focus on preventing or spotting HPV infection is crucial in the fight against cervical cancer.

"Getting your HPV vaccine [when young] is very important because this is a completely preventable disease," she said. And she believes every woman should have a discussion with her doctor as to which type and frequency of testing is best for her.

"Guidelines are not appropriate for every patient," Blank said. "Guidelines should be followed, but you also need some physician judgment in there as well."

Explore further: Age matters when it comes to screening for cervical cancer

More information: Stephanie Blank, M.D., director of Women's Health, Mount Sinai Downtown Chelsea Center and professor of obstetrics, gynecology and reproductive science, Icahn School of Medicine at Mount Sinai, New York City; Eva Chalas, M.D., chief of gynecological oncology and physician director, NYU Winthrop Hospital Cancer Center, Mineola, N.Y.; Sept. 12, 2017, news release, U.S. Preventive Services Task Force

The U.S. National Cancer Institute has more on cervical cancer.

Related Stories

Age matters when it comes to screening for cervical cancer

September 12, 2017
Getting checked for cervical cancer isn't one-size-fits-all. Draft guidelines released Tuesday show age makes a difference.

USPSTF: Ovarian cancer screen to be avoided for most women

July 20, 2017
(HealthDay)—The potential harms of ovarian cancer screening outweigh the benefits, so only very specific groups of women should be screened for the disease, the U.S. Preventive Services Task Force (USPSTF) says in a draft ...

Women should continue cervical cancer screening as they approach age 65

May 1, 2017
Cervical cancer is often thought of as a disease that primarily affects young women. Because of this, many older women fail to keep up with appropriate screening as they age. While current guidelines indicate that screening ...

Less frequent pap tests safe for most women, ob/gyn group says

October 22, 2012
(HealthDay)—Most women need testing for cervical cancer only every three to five years, rather than annually, according to the American College of Obstetricians and Gynecologists.

Screening, HPV vaccine can prevent cervical cancer: FDA

February 8, 2017
(HealthDay)—Women can reduce their risk of cervical cancer through vaccination and screening, the U.S. Food and Drug Administration says.

Chlamydia screening drops after change in cervical cancer screening guideline

July 11, 2017
A 2012 cervical cancer screening guideline change is associated with reduced testing for cervical cancer and chlamydia and reduced identification of chlamydia cases in young women. Screening for chlamydia, the most commonly-diagnosed ...

Recommended for you

Researchers discover specific tumor environment that triggers cells to metastasize

November 21, 2017
A team of bioengineers and bioinformaticians at the University of California San Diego have discovered how the environment surrounding a tumor can trigger metastatic behavior in cancer cells. Specifically, when tumor cells ...

New study points the way to therapy for rare cancer that targets the young

November 21, 2017
After years of rigorous research, a team of scientists has identified the genetic engine that drives a rare form of liver cancer. The findings offer prime targets for drugs to treat the usually lethal disease, fibrolamellar ...

Clinical trial suggests new cell therapy for relapsed leukemia patients

November 20, 2017
A significant proportion of children and young adults with treatment-resistant B-cell leukemia who participated in a small study achieved remission with the help of a new form of gene therapy, according to researchers at ...

Cell-weighing method could help doctors choose cancer drugs

November 20, 2017
Doctors have many drugs available to treat multiple myeloma, a type of blood cancer. However, there is no way to predict, by genetic markers or other means, how a patient will respond to a particular drug. This can lead to ...

Researchers discover a new target for 'triple-negative' breast cancer

November 20, 2017
So-called "triple-negative" breast cancer is a particularly aggressive and difficult-to-treat form. It accounts for only about 10 percent of breast cancer cases, but is responsible for about 25 percent of breast cancer fatalities.

Study reveals new mechanism used by cancer cells to disarm attacking immune cells

November 20, 2017
A new study by researchers at The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute (OSUCCC - James) identifies a substance released by pancreatic cancer cells that protects ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.